J. Neurol. 2020 Feb 01
A longitudinal study of cognitive function in multiple sclerosis: is decline inevitable?
Katsari M, Kasselimis DS, Giogkaraki E, Breza M, Evangelopoulos ME, Anagnostouli M, Andreadou E, Kilidireas C, Hotary A, Zalonis I, Koutsis G, Potagas C
Numerous cross-sectional studies report cognitive impairment in multiple sclerosis (MS), but longitudinal studies with sufficiently long-term follow-u ...
Read More
Source: PubMed
Arch Clin Neuropsychol 2020 Feb 01
Counterpoint: Links between traumatic brain injury and dementia remain poorly defined.
Barr WB
There has been considerable public interest in the topic of traumatic brain injury (TBI) as a risk factor for development of late-life dementia. A rev ...
Read More
Source: PubMed
J. Alzheimers Dis. 2020 Jan 28
Metabolic Profiles Help Discriminate Mild Cognitive Impairment from Dementia Stage in Alzheimer's Disease.
Jääskeläinen O, Hall A, Tiainen M, van Gils M, Lötjönen J, Kangas AJ, Helisalmi S, Pikkarainen M, Hallikainen M, Koivisto A, Hartikainen P, Hiltunen M, Ala-Korpela M, Soininen P, Soininen H, Herukka SK
Accurate differentiation between neurodegenerative diseases is developing quickly and has reached an effective level in disease recognition. However, ...
Read More
Source: PubMed
Neurology 2020 Feb 01
Quality improvement in dementia care: Dementia Management Quality Measurement Set 2018 Implementation Update.
Schultz SK, Llorente MD, Sanders AE, Tai WA, Bennett A, Shugarman S, Roca R
Read More
Source: PubMed
Brain Res. 2020 Jan 30
ApoE mimetic improves pathology and memory in a model of Alzheimer's disease.
Krishnamurthy K, Cantillana V, Wang H, Sullivan PM, Kolls BJ, Ge X, Lin Y, Mace B, Laskowitz DT
Alzheimer's disease (AD) is the most common form of dementia and is characterized pathologically by Aß plaques. Current treatments are purely symptoma ...
Read More
Source: PubMed
